Vanguard Global Advisers’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
Vanguard Global Advisers's ADMA Position: Q3 2026 in Review
Vanguard Global Advisers reduced its ADMA Biologics (ADMA) stake by 4.4% in Q3 2026, selling an estimated $37.2K and leaving 87,727 shares worth $880K. The position accounts for ﹤0.01% of the portfolio, ranked #1798.
Vanguard Global Advisers first reported a position in ADMA in Q1 2026 and has held it in 3 quarters since. 330 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- Vanguard Global Advisers held 87,727 shares of ADMA Biologics worth $880K as of Q3 2026.
- Vanguard Global Advisers sold 4,021 ADMA Biologics shares in Q3 2026, an estimated $37.2K.
- ADMA Biologics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1798 holding.
- Vanguard Global Advisers first reported a position in ADMA Biologics in Q1 2026 and has held it in 3 quarters since.
- 330 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.